NO20002434L - Oksazolidinonderivater og farmasøytiske preparater - Google Patents

Oksazolidinonderivater og farmasøytiske preparater

Info

Publication number
NO20002434L
NO20002434L NO20002434A NO20002434A NO20002434L NO 20002434 L NO20002434 L NO 20002434L NO 20002434 A NO20002434 A NO 20002434A NO 20002434 A NO20002434 A NO 20002434A NO 20002434 L NO20002434 L NO 20002434L
Authority
NO
Norway
Prior art keywords
pharmaceutical preparations
oxazolidinone derivatives
organisms
compound
formula
Prior art date
Application number
NO20002434A
Other languages
English (en)
Other versions
NO317291B1 (no
NO20002434D0 (no
Inventor
Jr Jackson B Hester
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO20002434D0 publication Critical patent/NO20002434D0/no
Publication of NO20002434L publication Critical patent/NO20002434L/no
Publication of NO317291B1 publication Critical patent/NO317291B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20002434A 1997-11-12 2000-05-11 Oksazolidinonderivater og farmasoytiske preparater NO317291B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6537697P 1997-11-12 1997-11-12
PCT/US1998/022639 WO1999024428A1 (en) 1997-11-12 1998-10-30 Oxazolidinone derivatives and pharmaceutical compositions

Publications (3)

Publication Number Publication Date
NO20002434D0 NO20002434D0 (no) 2000-05-11
NO20002434L true NO20002434L (no) 2000-05-11
NO317291B1 NO317291B1 (no) 2004-10-04

Family

ID=22062294

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002434A NO317291B1 (no) 1997-11-12 2000-05-11 Oksazolidinonderivater og farmasoytiske preparater

Country Status (21)

Country Link
US (1) US5998406A (no)
EP (1) EP1030852B1 (no)
JP (1) JP2001522849A (no)
KR (1) KR20010031953A (no)
CN (1) CN1154644C (no)
AT (1) ATE250054T1 (no)
AU (1) AU739055B2 (no)
BR (1) BR9813985A (no)
CA (1) CA2303959A1 (no)
DE (1) DE69818294T2 (no)
DK (1) DK1030852T3 (no)
ES (1) ES2207010T3 (no)
HU (1) HUP0100470A3 (no)
IL (1) IL136062A (no)
NO (1) NO317291B1 (no)
NZ (1) NZ504503A (no)
PT (1) PT1030852E (no)
RU (1) RU2215740C2 (no)
SK (1) SK284577B6 (no)
TR (1) TR200001330T2 (no)
WO (1) WO1999024428A1 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999064417A2 (en) 1998-06-05 1999-12-16 Astrazeneca Ab Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
KR100355345B1 (ko) * 2000-01-21 2002-10-12 한국과학기술연구원 티오펜환을 함유한 신규한 옥사졸리디논 유도체, 그의 제조방법 및 조성물
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
DE60304360T2 (de) * 2002-08-12 2006-11-16 Pharmacia & Upjohn Co. Llc, Kalamazoo N-aryl-2-oxazolidinone und deren derivate
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
MXPA06002188A (es) * 2003-08-25 2006-04-27 Warner Lambert Co Nuevos compuestos antimicrobianos de ariloxazolidinona.
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
KR100854211B1 (ko) * 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
CA2589250A1 (en) * 2004-11-29 2006-06-01 Pharmacia & Upjohn Company Llc Diazepine oxazolidinones as antibacterial agents
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) * 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE602006010702D1 (de) 2005-06-29 2010-01-07 Pharmacia & Upjohn Co Llc Homomorpholinoxazolidinone als antibakterielle mittel
DE102005045518A1 (de) 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
CA2624310C (en) 2005-10-04 2014-01-07 Bayer Healthcare Ag Polymorphic form of 5-chloro-n-({5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide
KR20080110877A (ko) 2006-03-31 2008-12-19 재단법인 이쯔우 연구소 헤테로환을 갖는 신규 화합물
CN101883768A (zh) 2007-10-02 2010-11-10 财团法人乙卯研究所 具有7元杂环的噁唑烷酮衍生物
EP2635589A1 (en) 2010-11-03 2013-09-11 Wockhardt Limited Process for the preparation of phosphoric acid mono- (l-{4- [(s) -5- (acetylaminomethyl) - 2 - oxo - oxazolidin- 3 - yl]- 2, 6 - difluorophenyl} - 4 -methoxymethylpiperidin- 4 - yl) ester
WO2015173664A1 (en) 2014-05-14 2015-11-19 Wockhardt Limited Process for the preparation of (5s)-n-{3-[3,5-difluoro-4-(4-hydroxy-4-methoxymethyl-piperidin-1-yl)-phenyl]-2-oxo-oxazolidin-5-ylmethyl}-acetamide

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801600A (en) * 1987-10-09 1989-01-31 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
CA1320730C (en) * 1987-10-16 1993-07-27 The Du Pont Merck Pharmaceutical Company Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
ES2059467T3 (es) * 1987-10-21 1994-11-16 Du Pont Merck Pharma Derivados de aminometil-oxooxazolidinil-etenilbenceno utiles como agentes antibacterianos.
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
JP2865211B2 (ja) * 1988-09-15 1999-03-08 ファルマシア・アンド・アップジョン・カンパニー ５’―インドリニル―５β―アミドメチルオキサゾリジン―２―オン類、３―（縮合環置換）フェニル―５β―アミドメチルオキサゾリジン―２―オン類および３―（窒素原子置換）フェニル―５β―アミドメチルオキサゾリジン―２―オン類
EP0610265B1 (en) * 1991-11-01 1996-12-27 PHARMACIA & UPJOHN COMPANY Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
CA2174107C (en) * 1993-11-22 2005-04-12 Steven J. Brickner Esters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones
JPH0873455A (ja) * 1994-03-15 1996-03-19 Upjohn Co:The オキサゾリジノン誘導体及びこれを有効成分とする医薬組成物
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
AU1277899A (en) 1999-05-31
TR200001330T2 (tr) 2000-11-21
EP1030852B1 (en) 2003-09-17
IL136062A (en) 2004-02-08
CN1154644C (zh) 2004-06-23
PT1030852E (pt) 2004-02-27
EP1030852A1 (en) 2000-08-30
SK6182000A3 (en) 2000-12-11
NO317291B1 (no) 2004-10-04
HUP0100470A3 (en) 2002-08-28
NZ504503A (en) 2002-10-25
DE69818294D1 (de) 2003-10-23
DK1030852T3 (da) 2003-12-22
SK284577B6 (sk) 2005-07-01
ES2207010T3 (es) 2004-05-16
CN1271358A (zh) 2000-10-25
US5998406A (en) 1999-12-07
NO20002434D0 (no) 2000-05-11
DE69818294T2 (de) 2004-07-08
JP2001522849A (ja) 2001-11-20
HK1030373A1 (en) 2001-05-04
ATE250054T1 (de) 2003-10-15
RU2215740C2 (ru) 2003-11-10
AU739055B2 (en) 2001-10-04
CA2303959A1 (en) 1999-05-20
WO1999024428A1 (en) 1999-05-20
HUP0100470A2 (hu) 2002-05-29
BR9813985A (pt) 2000-09-26
IL136062A0 (en) 2001-05-20
KR20010031953A (ko) 2001-04-16

Similar Documents

Publication Publication Date Title
NO20002434D0 (no) Oksazolidinonderivater og farmasøytiske preparater
DE69714418D1 (de) Azolylpiperazinylphenyloxazolidinone als antimikrobielle mittel
NO996269L (no) Kinolin-indol antimikrobielle midler, samt anvendelse og blandinger derav
GEP20002298B (en) Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment
BG103945A (bg) Производни на 4"-заместен-9-деоксо-9а-аза-9а- хомоеритромицин а
NO950297D0 (no) Prolinamidderivater
SE9604786D0 (sv) New compounds
NZ325837A (en) Carbamoyloxy derivatives of mutiline and their use as antibacterials
DE69721679D1 (de) Antimikrobielle Zusammensetzung.
NZ309151A (en) a 3-substituted cyano or carbamoyl pyrrole derivative and pharmaceutical composition
WO2001003685A3 (en) Novel prodrugs for antimicrobial amidines
PL358666A1 (en) 2-hydroxy-mutilin carbamate derivatives for antibacterial use
ATE246192T1 (de) Ethyliden-derivate tricyclyscher carbapenems
NZ333926A (en) Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
CA2386685A1 (en) Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases
DK0824539T3 (da) Dialkyltiacumicin-forbindelser
DE60005517D1 (de) Kaliumkanal-blockierende mittel
MY104109A (en) Antibacterial 9-deoxo-9a-allyl and propargyl-9a-aza-9a-homoerythromycin a derivatives.
MY122570A (en) Benzamide derivatives and drugs containing the same
BG101996A (en) 9-n-ethylenederivatives of 9(s)-erythromycylamine
DE69317058D1 (de) Die antibiotika ge 37468 a, b und c
NZ503027A (en) Use of rifamycin derivative for treating mastitis in a domestic animal
ZA966775B (en) Use of prostane derivatives and the combination thereof with antibiotics in the treatment of bacterial infections.
NO20013464L (no) Anvendelse av 3-isoksazolidinoner og hydroksylaminsyrer for behandling av infeksjoner
TR199700921T1 (xx) �nsanlarda g�r�len herpes-vir�s-8'in tedavisinde pensiklovir'in kullan�lmas�.